TLX250 CDx(ZERKAICS)

Search documents
Telix Pharmaceuticals (TLX) Update / Briefing Transcript
2025-08-28 01:32
Telix Pharmaceuticals (TLX) Update / Briefing August 27, 2025 08:30 PM ET Company ParticipantsChristian Behrenbruch - MD, Group CEO & DirectorNick Lorusso - VP - Biotech Equity ResearchDavid Stanton - Head of Healthcare Equity Research, AustraliaDavid Dai - DirectorConference Call ParticipantsRobert Burns - MD & Senior Healthcare AnalystDennis Hulme - Biotech AnalystAndrew Paine - Research Analyst - HealthcareDavid Bailey - Equity Research AnalystAndy Hsieh - Research Analyst, HealthcareJohn Hester - Senior ...